Bioanalytical testing involves analysis of drugs, biomarkers, and metabolites present in biological samples. Bioanalytical testing plays an essential role in each step of drug development and production. Qualitative and quantitative results obtained from validated testing provide valuable information to ensure the quality of the product.
Need for Outsourcing
Drugs undergo various stages in the research and development process carried out in pharmaceutical companies. Since multiple programs running at a time need a lot of capital, space, staff, and logistics, challenges such as limited resources and lack of scientific expertise arise in small and medium organization. Such organizations therefore opt for outsourcing.
Testing Life-threatening Blood Clot Disorder
Recently, LabCorp developed the “ADAMTS13” test to analyse acute thrombotic microangiopathy (TMA). This is a life-threatening disease in which red blood cells are destroyed due to development of blood clots in small blood vessels.
A new liquid chromatography-tandem mass spectrometry (LC-MS/MS) technology is used to perform the ADAMTS13 test. A fluorescent-based test is also available for this activity. The LC-MS/MS technology is a cost-effective solution, which offers seven tests per week and results can be delivered on the same day.
This test is an important diagnostic tool and assists in the required treatment of this rare syndrome. It also avoids unnecessary treatment cost.
Market Overview
According to Grand View Research, Inc., the global bioanalytical testing services market is set to achieve around USD 3 billion by 2025. Growing consumption of pharmaceutical products due to increasing awareness among individuals is a major driving factor for the market.
Small molecule bioanalytical testing accounted for the largest market share in 2016. Large molecule bioanalytical testing is also expected to exhibit rapid growth due to a strong pipeline of amino acid-based products or biologics.
In 2016, North America acquired the largest market share due to the presence of reliable pharmaceutical manufacturers. Asia Pacific is projected to show substantial growth in future.
Major players in the market include ICON plc; Covance Inc.; LabCorp; Charles River Laboratories International; and Pace Analytical Services.
In-Depth research report on Bioanalytical Testing Services Market:
No comments:
Post a Comment